241 related articles for article (PubMed ID: 31748410)
1. The intrinsically disordered C terminus of troponin T binds to troponin C to modulate myocardial force generation.
Johnston JR; Landim-Vieira M; Marques MA; de Oliveira GAP; Gonzalez-Martinez D; Moraes AH; He H; Iqbal A; Wilnai Y; Birk E; Zucker N; Silva JL; Chase PB; Pinto JR
J Biol Chem; 2019 Dec; 294(52):20054-20069. PubMed ID: 31748410
[TBL] [Abstract][Full Text] [Related]
2. Dilated Cardiomyopathy Mutations and Phosphorylation disrupt the Active Orientation of Cardiac Troponin C.
Mahmud Z; Dhami PS; Rans C; Liu PB; Hwang PM
J Mol Biol; 2021 Jun; 433(13):167010. PubMed ID: 33901537
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional impact of troponin C-mediated Ca
Gonzalez-Martinez D; Johnston JR; Landim-Vieira M; Ma W; Antipova O; Awan O; Irving TC; Bryant Chase P; Pinto JR
J Mol Cell Cardiol; 2018 Oct; 123():26-37. PubMed ID: 30138628
[TBL] [Abstract][Full Text] [Related]
4. Interactions at the NH2-terminal interface of cardiac troponin I modulate myofilament activation.
Rarick HM; Tang HP; Guo XD; Martin AF; Solaro RJ
J Mol Cell Cardiol; 1999 Feb; 31(2):363-75. PubMed ID: 10093049
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
Parvatiyar MS; Pinto JR
Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
Dyer EC; Jacques AM; Hoskins AC; Ward DG; Gallon CE; Messer AE; Kaski JP; Burch M; Kentish JC; Marston SB
Circ Heart Fail; 2009 Sep; 2(5):456-64. PubMed ID: 19808376
[TBL] [Abstract][Full Text] [Related]
7. Molecular Effects of cTnC DCM Mutations on Calcium Sensitivity and Myofilament Activation-An Integrated Multiscale Modeling Study.
Dewan S; McCabe KJ; Regnier M; McCulloch AD; Lindert S
J Phys Chem B; 2016 Aug; 120(33):8264-75. PubMed ID: 27133568
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments.
Chandra M; Montgomery DE; Kim JJ; Solaro RJ
J Mol Cell Cardiol; 1999 Apr; 31(4):867-80. PubMed ID: 10329214
[TBL] [Abstract][Full Text] [Related]
9. A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.
Parvatiyar MS; Landstrom AP; Figueiredo-Freitas C; Potter JD; Ackerman MJ; Pinto JR
J Biol Chem; 2012 Sep; 287(38):31845-55. PubMed ID: 22815480
[TBL] [Abstract][Full Text] [Related]
10. Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function.
Sumandea MP; Vahebi S; Sumandea CA; Garcia-Cazarin ML; Staidle J; Homsher E
Biochemistry; 2009 Aug; 48(32):7722-31. PubMed ID: 19586048
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ - and cross-bridge-dependent changes in N- and C-terminal structure of troponin C in rat cardiac muscle.
Martyn DA; Regnier M; Xu D; Gordon AM
Biophys J; 2001 Jan; 80(1):360-70. PubMed ID: 11159408
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cardiac troponin C with calmodulin antagonist [corrected] W7 in the presence of three functional regions of cardiac troponin I.
Li MX; Hoffman RM; Sykes BD
Biochemistry; 2006 Aug; 45(32):9833-40. PubMed ID: 16893183
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide.
Li MX; Spyracopoulos L; Beier N; Putkey JA; Sykes BD
Biochemistry; 2000 Aug; 39(30):8782-90. PubMed ID: 10913289
[TBL] [Abstract][Full Text] [Related]
14. The cardiac-specific N-terminal region of troponin I positions the regulatory domain of troponin C.
Hwang PM; Cai F; Pineda-Sanabria SE; Corson DC; Sykes BD
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14412-7. PubMed ID: 25246568
[TBL] [Abstract][Full Text] [Related]
15. The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q.
Robertson IM; Sevrieva I; Li MX; Irving M; Sun YB; Sykes BD
J Mol Cell Cardiol; 2015 Oct; 87():257-69. PubMed ID: 26341255
[TBL] [Abstract][Full Text] [Related]
16. Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?
Dweck D; Hus N; Potter JD
J Biol Chem; 2008 Nov; 283(48):33119-28. PubMed ID: 18820258
[TBL] [Abstract][Full Text] [Related]
17. Ca(2+) induces an extended conformation of the inhibitory region of troponin I in cardiac muscle troponin.
Dong WJ; Xing J; Robinson JM; Cheung HC
J Mol Biol; 2001 Nov; 314(1):51-61. PubMed ID: 11724531
[TBL] [Abstract][Full Text] [Related]
18. The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.
Sorsa T; Pollesello P; Solaro RJ
Mol Cell Biochem; 2004 Nov; 266(1-2):87-107. PubMed ID: 15646030
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.
Pinto JR; Siegfried JD; Parvatiyar MS; Li D; Norton N; Jones MA; Liang J; Potter JD; Hershberger RE
J Biol Chem; 2011 Sep; 286(39):34404-12. PubMed ID: 21832052
[TBL] [Abstract][Full Text] [Related]
20. Calcium binding kinetics of troponin C strongly modulate cooperative activation and tension kinetics in cardiac muscle.
Kreutziger KL; Piroddi N; McMichael JT; Tesi C; Poggesi C; Regnier M
J Mol Cell Cardiol; 2011 Jan; 50(1):165-74. PubMed ID: 21035455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
